Diagnostic implications and inpatient mortality related to tuberculosis at Jimma Medical Center, southwest Ethiopia.

Diagnosis Ethiopia HIV Mortality Tuberculosis

Journal

Journal of clinical tuberculosis and other mycobacterial diseases
ISSN: 2405-5794
Titre abrégé: J Clin Tuberc Other Mycobact Dis
Pays: England
ID NLM: 101682877

Informations de publication

Date de publication:
May 2021
Historique:
entrez: 8 2 2021
pubmed: 9 2 2021
medline: 9 2 2021
Statut: epublish

Résumé

Tuberculosis (TB) is one of the major public health problems in Ethiopia. Determining discharge outcome of TB cases helps to understand the effectiveness of TB diagnosis effort to improve case management. The objective of this study was to assess discharge outcomes and factors associated with death among patients on TB treatment admitted in a referral hospital in southwest Ethiopia. A retrospective study was conducted in Jimma Medical Center by reviewing medical records of TB patients (age ≥15 years) admitted to medical wards from January 2015 to December 2017. Demographic and related data was collected using data collection format. The clinical evaluation outcome of an individual patient at discharge was recorded. Descriptive statistics were used to summarize participant characteristics. Multivariate logistic regression analyses were used to evaluate the risk factors for TB mortality. Among 465 patients included in the review, 225 (48.4%) were pulmonary (PTB) and 240 (51.6%) extra-pulmonary TB (EPTB) cases. Overall, 190 (40.9%) had bacteriologically confirmed for TB. HIV status was documented for 340 (73.1%) of them; 93 (27.4%) were found to be positive. The prevalence of HIV infection among EPTB and PTB cases was 50/275 (18.2%) and 43/190 (22.8%), respectively. A quarter of the patient, 114 (24.5%), died in the hospital while the rest were discharged with clinical improvement. Compared to smear positive PTB, the risk of death was two times higher in patients with smear negative PTB cases (aOR 2.3, 95% CI: 1.3-4.2). TB patients with coronary obstructive pulmonary disease (COPD) (aOR 4.6, 95% CI: 1.3-16.7), diabetes mellitus (aOR 5.7, 95% CI: 1.5-23.7), heart disease (aOR 3.8, 95% CI: 1.4-10.4) had about four-fold increased risk of death. HIV-positive patients had a higher risk of mortality (aOR 2.9, 95% CI: 1.7-5.0) than HIV-negative patients. The risk of death was not affected by the type of TB diagnosed, as 27.6% of EPTB and 31.9% PTB were died (p = 0.457). TB was associated with high inpatient mortality at Jimma Medical Center. Mortality was found to be higher among unconfirmed cases, those with COPD, diabetes mellitus, heart disease and HIV infection. Thus, any effort to curtail mortality in such high TB burden setting should focus on improving TB diagnosis and addressing major comorbid medical conditions.

Sections du résumé

BACKGROUND BACKGROUND
Tuberculosis (TB) is one of the major public health problems in Ethiopia. Determining discharge outcome of TB cases helps to understand the effectiveness of TB diagnosis effort to improve case management. The objective of this study was to assess discharge outcomes and factors associated with death among patients on TB treatment admitted in a referral hospital in southwest Ethiopia.
METHODS METHODS
A retrospective study was conducted in Jimma Medical Center by reviewing medical records of TB patients (age ≥15 years) admitted to medical wards from January 2015 to December 2017. Demographic and related data was collected using data collection format. The clinical evaluation outcome of an individual patient at discharge was recorded. Descriptive statistics were used to summarize participant characteristics. Multivariate logistic regression analyses were used to evaluate the risk factors for TB mortality.
RESULTS RESULTS
Among 465 patients included in the review, 225 (48.4%) were pulmonary (PTB) and 240 (51.6%) extra-pulmonary TB (EPTB) cases. Overall, 190 (40.9%) had bacteriologically confirmed for TB. HIV status was documented for 340 (73.1%) of them; 93 (27.4%) were found to be positive. The prevalence of HIV infection among EPTB and PTB cases was 50/275 (18.2%) and 43/190 (22.8%), respectively. A quarter of the patient, 114 (24.5%), died in the hospital while the rest were discharged with clinical improvement. Compared to smear positive PTB, the risk of death was two times higher in patients with smear negative PTB cases (aOR 2.3, 95% CI: 1.3-4.2). TB patients with coronary obstructive pulmonary disease (COPD) (aOR 4.6, 95% CI: 1.3-16.7), diabetes mellitus (aOR 5.7, 95% CI: 1.5-23.7), heart disease (aOR 3.8, 95% CI: 1.4-10.4) had about four-fold increased risk of death. HIV-positive patients had a higher risk of mortality (aOR 2.9, 95% CI: 1.7-5.0) than HIV-negative patients. The risk of death was not affected by the type of TB diagnosed, as 27.6% of EPTB and 31.9% PTB were died (p = 0.457).
CONCLUSION CONCLUSIONS
TB was associated with high inpatient mortality at Jimma Medical Center. Mortality was found to be higher among unconfirmed cases, those with COPD, diabetes mellitus, heart disease and HIV infection. Thus, any effort to curtail mortality in such high TB burden setting should focus on improving TB diagnosis and addressing major comorbid medical conditions.

Identifiants

pubmed: 33553681
doi: 10.1016/j.jctube.2021.100220
pii: S2405-5794(21)00009-7
pmc: PMC7846922
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100220

Informations de copyright

© 2021 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

BMC Res Notes. 2012 Dec 12;5:682
pubmed: 23234241
Int J Tuberc Lung Dis. 2014 Jun;18(6):635-9
pubmed: 24903931
PLoS One. 2015 Dec 15;10(12):e0144244
pubmed: 26669737
J Diet Suppl. 2019;16(5):602-610
pubmed: 29958051
BMC Infect Dis. 2011 May 16;11:127
pubmed: 21575187
BMC Res Notes. 2018 Oct 4;11(1):696
pubmed: 30286801
Curr Opin HIV AIDS. 2019 Jan;14(1):46-54
pubmed: 30346311
BMC Public Health. 2016 Aug 25;16:883
pubmed: 27561794
PLoS One. 2016 Feb 26;11(2):e0150560
pubmed: 26918458
BMC Infect Dis. 2019 Feb 11;19(1):132
pubmed: 30744603
Interdiscip Perspect Infect Dis. 2010;2010:412624
pubmed: 20508810
BMC Public Health. 2009 Oct 04;9:371
pubmed: 19799801
Tanzan J Health Res. 2011 Jan;13(1):21-6
pubmed: 24409643
Indian J Tuberc. 2019 Jan;66(1):99-104
pubmed: 30797292
Int J Mycobacteriol. 2017 Oct-Dec;6(4):356-359
pubmed: 29171449
J Clin Tuberc Other Mycobact Dis. 2019 Dec 12;18:100140
pubmed: 31909226
Int J Tuberc Lung Dis. 2013 Oct;17(10):1310-6
pubmed: 24025383
Int J Mycobacteriol. 2019 Jan-Mar;8(1):35-41
pubmed: 30860177

Auteurs

Wakjira Kebede (W)

Mycobacteriology Research Center, Jimma University, Ethiopia.
School of Medical Laboratory Science, Institute of Health, Jimma University, Ethiopia.

Esayas Kebede Gudina (EK)

Department of Internal Medicine, Jimma University Medical Center, Jimma University, Ethiopia.

Getu Balay (G)

School of Medical Laboratory Science, Institute of Health, Jimma University, Ethiopia.

Gemeda Abebe (G)

Mycobacteriology Research Center, Jimma University, Ethiopia.
School of Medical Laboratory Science, Institute of Health, Jimma University, Ethiopia.

Classifications MeSH